March 2019: Meducom supports manuscript development on real-life experiences in the treatment of gastric cancer
At the request of the author, Meducom assisted in the development of a manuscript on for publication in Drugs R&D. Upon registration of an oncology drug for advanced gastric cancer in Europe, a multinational, prospective, open cohort compliance study was initiated. The observational study collected important parameters for daily oncological practices from 125 patients in over 20 centres in Europe and provides important information regarding factors that affect patient compliance and self-administration experiences. Meducom supported with the analysis of the vast amount of data collected, as well as with manuscript writing and editing. The collective experiences described in the article provide valuable information for oncologists in their treatment decision making process for gastric cancer.